The AMPA antagonist ZK 200775 in patients with acute ischaemic stroke: a double-blind, multicentre, placebo-controlled safety and tolerability study.

MLA

Walters, M. R., et al. “The AMPA Antagonist ZK 200775 in Patients with Acute Ischaemic Stroke: A Double-Blind, Multicentre, Placebo-Controlled Safety and Tolerability Study.” Cerebrovascular Diseases (Basel, Switzerland), vol. 20, no. 5, 2005, pp. 304–09. EBSCOhost, https://doi.org/10.1159/000087929.

APA

Walters, M. R., Kaste, M., Lees, K. R., Diener, H. C., Hommel, M., De Keyser, J., Steiner, H., & Versavel, M. (2005). The AMPA antagonist ZK 200775 in patients with acute ischaemic stroke: a double-blind, multicentre, placebo-controlled safety and tolerability study. Cerebrovascular Diseases (Basel, Switzerland), 20(5), 304–309. https://doi.org/10.1159/000087929

Chicago

Walters, M R, Markku Kaste, K R Lees, Hans C Diener, M Hommel, Jacques De Keyser, Heike Steiner, and Mark Versavel. 2005. “The AMPA Antagonist ZK 200775 in Patients with Acute Ischaemic Stroke: A Double-Blind, Multicentre, Placebo-Controlled Safety and Tolerability Study.” Cerebrovascular Diseases (Basel, Switzerland) 20 (5): 304–9. doi:10.1159/000087929.